Therapeutic Asset Ratings
622 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
PRT1419
Breast Cancer
Prelude Therapeutics
P1
C
(38)
Capmatinib
Breast Cancer
M.D. Anderson Cancer Center
P1/2
C
(37)
[177Lu]Lu-A9-0631
Breast Cancer
Alpha-9 Oncology USA Inc.
P1
C
(36)
²¹²pb-dotam-grpr1
Breast Cancer
Orano Med Theranostics, SAS
P1
C
(36)
[225Ac]Ac-A9-0642
Breast Cancer
Alpha-9 Oncology USA Inc.
P1
C
(36)
[68ga]ga-dwj155
Breast Cancer
Novartis Pharmaceuticals
P1
C
(36)
ac682
Breast Cancer
Accutar Biotechnology Inc
P1
C
(36)
ac699
Breast Cancer
Accutar Biotechnology Inc
P1
C
(36)
agx101
Breast Cancer
Angiex, Inc.
P1
C
(36)
Alta2618
Breast Cancer
Alterome Therapeutics, Inc.
P1
C
(36)
Amivantamab-Vmjw
Breast Cancer
Fate Therapeutics
P1
C
(36)
Atv-1601
Breast Cancer
Atavistik Bio, Inc
P1
C
(36)
Autologous Anti-Cd19 Car-Expressing T Lymphocytes
Breast Cancer
Anusha Kalbasi
P1
C
(36)
Autologous, Engineered T Cells Targeting Tp53 R175H
Breast Cancer
AstraZeneca
P1
C
(36)
ava6000
Breast Cancer
Avacta Life Sciences Ltd
P1
C
(36)
Avidin-Biotin-Dota-90Y
Breast Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
P1
C
(36)
Azelaic Acid
Breast Cancer
Virginia Commonwealth University
P1
C
(36)
ba1302
Breast Cancer
Shandong Boan Biotechnology Co., Ltd
P1
C
(36)
Bbi-940
Breast Cancer
Boundless Bio, Inc.
P1
C
(36)
bg-68501
Breast Cancer
BeiGene
P1
C
(36)
bg-75202
Breast Cancer
BeOne Medicines
P1
C
(36)
Bl-B16D1
Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
P1
C
(36)
Bl-M02D1
Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
P1
C
(36)
Bl-M17D1
Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
P1
C
(36)
Brodalumab
Breast Cancer
Brian Henick, MD
P1
C
(36)
Showing 451 to 475 of 622 assets
Previous
Page 19 of 25
Next